The settlement covers more than 14,000 participants and beneficiaries in Teva’s $1.9 billion 401(k) plan. It resolves a proposed class action accusing plan fiduciaries of allowing expensive mutual funds to remain in the plan without properly considering cheaper alternatives such as collective investment trusts, lower-cost share classes, and passively managed investments.
The deal, announced in filings Wednesday, comes eight months ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
